BlackRock, Inc. 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 6:45 pm Sale |
2024-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
5,466,102 11.000% |
-2,741,446 (-33.40%) |
Filing |
| 2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
8,207,548 18.700% |
1,521,198 (+22.75%) |
Filing |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
6,686,350 15.400% |
114,912 (+1.75%) |
Filing |
| 2022-01-27 5:14 pm Unchanged |
2021-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
6,571,438 15.400% |
0 (Unchanged) |
Filing |
| 2022-01-26 09:16 am Purchase |
2021-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
6,571,438 15.400% |
1,138,066 (+20.95%) |
Filing |
| 2021-01-26 2:22 pm Purchase |
2020-12-31 | 13G | REGENXBIO Inc. RGNX |
BlackRock Inc. BLK |
5,433,372 14.500% |
204,492 (+3.91%) |
Filing |